We are monitoring the impact of COVID-19 on Europe Liver Disease Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1652
Share on
Share on

Europe Liver Disease Treatment Market Research Report – Segmented By Treatment Modality, Disease Type and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1652
Pages: 145

Europe Liver Disease Treatment Market Size (2020 to 2025)

The size of the Liver Disease Treatment Market the European region is expected to reach USD 3.62 billion by 2025 from USD 2.08 billion in 2020, growing at a CAGR of 11.56% during the forecast period.

As the second largest internal organ, liver performs many complex functions in the body (bile secretion, toxin removal, and fighting infections, etc.). Malfunctioning of liver can be life-threatening as it can cause multiple acute and chronic diseases (hepatitis, non-alcoholic fatty liver disease, liver cancer, liver tumour, and liver cirrhosis, among others). The initial symptoms of liver damage include nausea, fatigue, diarrhoea, jaundice, swollen abdomen, and mental disorientation among other. Europe is among one of the leading markets for Liver Disease Treatment Drugs. As per a report, liver cirrhosis cause 170,000 deaths in Europe annually. Within Europe, Germany, France and United Kingdom accounts for largest share of liver disease treatment market.

The growth of Liver Disease Treatment market is majorly driven by factors such as boost in Research & Development investment, growth in geriatric population, and unmet needs for the treatment of liver cancer.  Europe is known for heavy drinking population in the world, therefore alcohol induced liver diseases is also responsible for spiking the demand for the product. Also, growing obese population has also increased the risk of non-alcoholic fatty liver disease which is caused by build-up of fat in the liver.

The key restraints of the market are complex drug approval procedure, side-effects of the product (fatigue, fever, and depression), and high cost incurred for product’s R&D process.

This research report has been segmented and sub-segmented into the following categories:

By Treatment Modality:

  • Antiviral
  • Vaccines
  • Chemotherapy
  • Immunosuppressive Agents
  • Corticosteroids

By Disease Type:

  • Hepatitis
  • Non-Alcoholic Fatty Liver Disease
  • Alcohol-Induced
  • Liver Cancer

By Country:

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Rest of Europe

Companies playing a key role in the European Liver Disease Treatment Market profiled in the report are Gilead Science Inc. (U.S.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Johnson & Johnson (U.S.), Novartis (Switzerland), Roche (Switzerland), Sanofi-Aventis (France), Abbott Laboratories (U.S.), Bayer Schering AG (Germany) and AstraZeneca (United Kingdom).

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 Treatment Modality                                               

                                5.1.1 Introduction                           

                                5.1.2 Antiviral                    

                                5.1.3 Vaccines                   

                                5.1.4 Chemotherapy                      

                                5.1.5 Immunosuppressive Agents                           

                                5.1.6 Corticosteroids                      

                                5.1.7 Others                      

                                5.1.8  Y-o-Y Growth Analysis, By Product                              

                                5.1.9  Market Attractiveness Analysis, By Product                            

                                5.1.10 Market Share Analysis, By Product                             

                5.2 Disease Type                                             

                                5.2.1 Introduction                           

                                5.2.2 Hepatitis                  

                                5.2.3 Non-Alcoholic Fatty Liver Disease                 

                                5.2.4 Alcohol Induced                    

                                5.2.5 Liver Cancer                            

                                5.2.6 Others                      

                                5.2.7  Y-o-Y Growth Analysis, By Type                    

                                5.2.8  Market Attractiveness Analysis, By Type                  

                                5.2.9  Market Share Analysis, By Type                    

  1. Geographical Analysis

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Type 

                                                6.1.3.4 By Application    

                                                6.1.3.5 By Indication       

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Type 

                                                6.1.4.4 By Application    

                                                6.1.4.5 By Indication       

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Type 

                                                6.1.5.4 By Application    

                                                6.1.5.5 By Indication       

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Gilead Science Inc                                    

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Pfizer Inc.                                    

                8.3 Merck & Co.                                               

                8.4 Johnson & Johnson                                 

                8.5 Novartis                                       

                8.6 Roche                                           

                8.7 Sanofi-Aventis                                          

                8.8 Abbott Laboratories                                               

                8.9 Bayer Schering AG                                   

                8.10 AstraZeneca                                            

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

  1. a) List of Tables
  2. b) List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  2. Europe Antiviral Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Chemotherapy Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Immunosuppressive Agents Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Corticosteroids Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  9. Europe Hepatitis Market, By Region, From 2020 to 2025 (USD Billion)
  10. Europe Non-Alcoholic Fatty Liver Disease Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Alcohol Induced Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Liver Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  14. U.K. Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  15. U.K. Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  16. Germany Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  17. Germany Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  18. France Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  19. France Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  20. Italy Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  21. Italy Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  22. Spain Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  23. Spain Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample